BioGaia AB (publ) (BIOG-B) - Cash Flow Conversion Efficiency
Based on the latest financial reports, BioGaia AB (publ) (BIOG-B) has a cash flow conversion efficiency ratio of 0.050x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr70.36 Million ≈ $7.57 Million USD) by net assets (Skr1.40 Billion ≈ $150.94 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See BIOG-B defensive interval ratio to measure how many days the company can operate on defensive assets alone.
BioGaia AB (publ) - Cash Flow Conversion Efficiency Trend (2002–2025)
This chart illustrates how BioGaia AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
BioGaia AB (publ) Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BioGaia AB (publ) ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
EmbedWay Tech(Shanghai)Corp
SHG:603496
|
0.038x |
|
Henan Zhongyuan Expressway Co Ltd
SHG:600020
|
0.063x |
|
Neuberger Berman Next Generation Connectivity Fund Inc
NYSE:NBXG
|
N/A |
|
Bengang Steel Plates Co Ltd
SHE:000761
|
-0.062x |
|
Chengdu Yunda Technology Co Ltd
SHE:300440
|
0.004x |
|
CS Wind Corp
KO:112610
|
-0.001x |
|
Guangdong CHJ Industry Co Ltd
SHE:002345
|
-0.164x |
|
Hilan Ltd
TA:HLAN
|
0.096x |
Annual Cash Flow Conversion Efficiency for BioGaia AB (publ) (2002–2025)
The table below shows the annual cash flow conversion efficiency of BioGaia AB (publ) from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see BioGaia AB (publ) (BIOG-B) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr1.31 Billion ≈ $141.43 Million |
Skr306.57 Million ≈ $32.99 Million |
0.233x | +7.75% |
| 2024-12-31 | Skr1.72 Billion ≈ $185.52 Million |
Skr373.22 Million ≈ $40.16 Million |
0.216x | +3.19% |
| 2023-12-31 | Skr2.03 Billion ≈ $218.50 Million |
Skr425.96 Million ≈ $45.84 Million |
0.210x | +29.74% |
| 2022-12-31 | Skr1.97 Billion ≈ $212.26 Million |
Skr318.94 Million ≈ $34.32 Million |
0.162x | +36.82% |
| 2021-12-31 | Skr1.88 Billion ≈ $202.03 Million |
Skr221.88 Million ≈ $23.88 Million |
0.118x | -6.72% |
| 2020-12-31 | Skr1.75 Billion ≈ $187.92 Million |
Skr221.26 Million ≈ $23.81 Million |
0.127x | -56.48% |
| 2019-12-31 | Skr507.87 Million ≈ $54.66 Million |
Skr147.85 Million ≈ $15.91 Million |
0.291x | -19.22% |
| 2018-12-31 | Skr508.12 Million ≈ $54.68 Million |
Skr183.12 Million ≈ $19.71 Million |
0.360x | -24.90% |
| 2017-12-31 | Skr463.89 Million ≈ $49.92 Million |
Skr222.62 Million ≈ $23.96 Million |
0.480x | +34.69% |
| 2016-12-31 | Skr415.18 Million ≈ $44.68 Million |
Skr147.93 Million ≈ $15.92 Million |
0.356x | +20.03% |
| 2015-12-31 | Skr395.83 Million ≈ $42.60 Million |
Skr117.50 Million ≈ $12.64 Million |
0.297x | -17.76% |
| 2014-12-31 | Skr344.59 Million ≈ $37.08 Million |
Skr124.38 Million ≈ $13.39 Million |
0.361x | +45.81% |
| 2013-12-31 | Skr316.86 Million ≈ $34.10 Million |
Skr78.44 Million ≈ $8.44 Million |
0.248x | -66.30% |
| 2012-12-31 | Skr456.79 Million ≈ $49.16 Million |
Skr335.56 Million ≈ $36.11 Million |
0.735x | +132.47% |
| 2011-12-31 | Skr230.35 Million ≈ $24.79 Million |
Skr72.79 Million ≈ $7.83 Million |
0.316x | -14.17% |
| 2010-12-31 | Skr187.32 Million ≈ $20.16 Million |
Skr68.97 Million ≈ $7.42 Million |
0.368x | +11.31% |
| 2009-12-31 | Skr161.12 Million ≈ $17.34 Million |
Skr53.29 Million ≈ $5.73 Million |
0.331x | +128.07% |
| 2008-12-31 | Skr132.42 Million ≈ $14.25 Million |
Skr19.20 Million ≈ $2.07 Million |
0.145x | +170.52% |
| 2007-12-31 | Skr94.91 Million ≈ $10.21 Million |
Skr5.09 Million ≈ $547.55K |
0.054x | +580.80% |
| 2006-12-31 | Skr74.53 Million ≈ $8.02 Million |
Skr-831.00K ≈ $-89.43K |
-0.011x | +91.97% |
| 2005-12-31 | Skr71.78 Million ≈ $7.72 Million |
Skr-9.97 Million ≈ $-1.07 Million |
-0.139x | -155.28% |
| 2004-12-31 | Skr91.50 Million ≈ $9.85 Million |
Skr22.99 Million ≈ $2.47 Million |
0.251x | +27.74% |
| 2003-12-31 | Skr114.85 Million ≈ $12.36 Million |
Skr22.59 Million ≈ $2.43 Million |
0.197x | -14.88% |
| 2002-12-31 | Skr127.99 Million ≈ $13.77 Million |
Skr29.57 Million ≈ $3.18 Million |
0.231x | -- |
About BioGaia AB (publ)
BioGaia AB (publ), a healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand. It operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well … Read more